Medonic Pharmaceuticals Private Limited
About Medonic Pharmaceuticals Private Limited
Data last updated:
Medonic Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 09 January 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2023PTC409661.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Sandeep Kumar (Managing Director) and Deepak Shahi.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 48 Pocket 13 Rohini Sector 24 Near Babosha Mandir, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.87 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹4,134 (net margin -1.4%) and EBITDA of ₹3,460 (EBITDA margin 1.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medonic Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressHouse No 48 Pocket 13 Rohini Sector 24 Near Babosha Mandir, Delhi, India – 110085
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medonic Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Medonic Pharmaceuticals Private Limited, buy the company report.
Financials of Medonic Pharmaceuticals Private Limited
FY 2025 filings availableMedonic Pharmaceuticals Private Limited reported revenue of ₹2.87 Lakh (up 380% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 380% in the latest year. EBITDA rose 106% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹3,460 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹4,134 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.2% | ||
| Net Profit Margin | -1.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Medonic Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medonic Pharmaceuticals Private Limited
Medonic Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Shahi | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
| Sandeep Kumar | Managing Director | 09 Jan 2023 | 3 Years 9 Months | Current |
| Ranjeet Kumar | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Medonic Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medonic Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medonic Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medonic Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Deepak Shahi was appointed as Director on 09 Jan 2023.
Frequently asked questions
Medonic Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 09 January 2023 (3+ years old) and is registered under CIN U51909DL2023PTC409661.
Medonic Pharmaceuticals has 3 current directors:
- Sandeep Kumar - Managing Director
- Deepak Shahi - Director
- Ranjeet Kumar - Director
The latest financial statements of Medonic Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Medonic Pharmaceuticals is U51909DL2023PTC409661. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medonic Pharmaceuticals was incorporated on 09 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Deepak Shahi was appointed as Director on 09 Jan 2023. Ranjeet Kumar was appointed as Director on 09 Jan 2023. Sandeep Kumar was appointed as Managing Director on 09 Jan 2023.
The registered office of Medonic Pharmaceuticals is at House No 48 Pocket 13 Rohini Sector 24 Near Babosha Mandir, Delhi, India – 110085.
Medonic Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Medonic Pharmaceuticals is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.
Medonic Pharmaceuticals can be reached at its registered office: House No 48 Pocket 13 Rohini Sector 24 Near Babosha Mandir, Delhi, India – 110085.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
